AIM
RPTP

Acrospire Investment Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Acrospire Investment Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,451
Closed -$31K – 2641
2016
Q3 		$31K Buy
+3,451
New +$24.5K 0.02% 1335

Acrospire Investment Management's RPTP Position: Q4 2016 in Review

Acrospire Investment Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 3,451 shares — an estimated $31K sold.

Acrospire Investment Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $31K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Acrospire Investment Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 3,451 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $31K.
  • Acrospire Investment Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Acrospire Investment Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $31K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.